Neurol. praxi. 2018;19(5):350-358 | DOI: 10.36290/neu.2018.117

Natural course of multiple sclerosis could be positively intervened by optimal nutrition

prof. RNDr. Jan Krejsek, CSc.
Ústav klinické imunologie a alergologie, LF UK a FN Hradec Králové

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the central nervous systeme. It is characterizedby the loss of the homeostatic regulations of the immune systeme comprising both innate and specific T cell mediatedimmunity resulting in the abnormal functional polarisation of T cells into Th17 and Th1 subsets together with the participation ofabnormal B cells. Drugs used in clinical practice are targeting different steps of the inflammatory immunopathological process.The effect of this treatment could be enhanced by the optimal life style of MS patients. The inflammation in MS patients couldbe simply targeted by optimal nutrition. The special emphasize should be paid to the optimalisation of the gut microbiota. Thenutrition should be enriched for all components modulating inflammation in MS patients. These comprise vitamine D, vitamineB, vitamine C, polyunsaturated fatty acids, prebiotics, probiotics and the substances of herbal origin, especially polyphenols.

Keywords: multiple sclerosis, inflammation, neurodegeneration, nutrition, microbiota, vitamins, fatty acids, prebiotics, probiotics, polyphenols

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejsek J. Natural course of multiple sclerosis could be positively intervened by optimal nutrition. Neurol. praxi. 2018;19(5):350-358. doi: 10.36290/neu.2018.117.
Download citation

References

  1. Alwarawrah Y, Kiernan K, Maclver NJ. Changes in nutritional status impact immune cell metabolism and function. Frontiers Immunol 2018; 9(1055): doi: 10.3389/fimmu.2018.01055. Go to original source... Go to PubMed...
  2. Azad AK, Sarker M, Li T, Yin J. Probiotic species in the modulation of gut microbiota: an overview. BioMed Research Int 2018; doi.org/10.1155/2018/9478630.
  3. Battino M, Giampieri F, Pistollato F, Sureda A, de Oliveira MR, Pittalá V, Fallarino F, Nabavi SF, Atanasov AG, Nabavi SM. Nrf2 as regulator of innate immunity: a molecular Swiss army knife! Biotechnol Adv 2018; 36(2): 358-370. Go to original source... Go to PubMed...
  4. Colpitts SL, Kasper LH. Influence of the gut microbiome on autoimmunity in the central nervous system. J Immunol 2017; 198: 596-604. Go to original source... Go to PubMed...
  5. Dargahi N, Katsara M, Tselios T, Androutsou ME, de Courten M, Matsoukas J, Apostolopoulos V. Multiple sclerosis: immunopathology and treatment update. Brain Sci 2017; 7(78): doi: 10.3390/brainsci7070078. Go to original source... Go to PubMed...
  6. Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, Witkowski JM, Franceschi C. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Frontiers Immunol 2018; 8(1960): doi: 10.3389/fimmu.2017.01960. Go to original source... Go to PubMed...
  7. Ingram CJE, Mulcare ChA, Itan Y, Thomas MG, Swallow DM. Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet 2009; 124: 579-591. Go to original source... Go to PubMed...
  8. Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, Zaheer S, Iyer SS, Zaheer A. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1(1). pii: 1003.
  9. Krejsek J, Andrýs C, Krčmová I. Imunologie člověka, Garamon, Hradec Králové, 2016 ISBN: 978-80-86472-74-4.
  10. Ma N, Guo P, Zhang J, He T, Kim SW, Zhang G, Ma X. Nutrients mediate intestinal bacteria-mucosal immune crosstalk. Frontiers Immunol 2018; 9(5): doi: 10.3389/fimmu.2018.00005. Go to original source... Go to PubMed...
  11. Matarese G, Procaccini C, De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol 2008; 84(4): 893-9. Go to original source... Go to PubMed...
  12. Morimoto Y, Izumi H, Kuroda E. Significance of persistent inflammation in respiratory disorders induced by nanoparticles. J Immunol Res 2014; 962871. doi: 10.1155/2014/962871. Go to original source... Go to PubMed...
  13. Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci 2018; 19(4): pii: E954. Go to original source...
  14. Parnell GP, Booth DR. The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to ms pathogenesis and identify novel therapeutic opportunities. Front Immunol. 2017 Apr 18;8:425. doi: 10.3389/fimmu.2017.00425.eCollection 2017. Go to original source... Go to PubMed...
  15. Ransohoff RM, Brown MA. Innate immunity in the central nervous systém. J Clin Invest 2012; 122(4): 1164-1171. Go to original source... Go to PubMed...
  16. Statovci D, Aguilera M, MacSharry J, Melgar S. The impact of western diet and nutrients on the microbiota and immune response at mucosal interfaces. Frontiers Immunol 2017; 8(838): doi: 10.3389/fimmu.2017.00838. Go to original source... Go to PubMed...
  17. Sujuan D, Hongmei J, Jun F. Regulation of immune function by polyphenols. J Immunol Res 2018. doi. org/101155/20181264074.
  18. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Ann Neurol 2017; 81: 369-382. Go to original source... Go to PubMed...
  19. Tsilingiri K, Rescigno M. Postbiotics: what else? Beneficial Microb 2013; 4(1): 101-107. Go to original source... Go to PubMed...
  20. Vieira AT, Fukumori C, Ferreira CM. New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunol 2016; 5: e87. Go to original source...
  21. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017; doi: 10.1007/s00018-017-2550-9. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.